Adragos and Maisons-Alfort: A New Chapter
We are pleased to welcome the Maisons-Alfort facility into its global network. This integration strengthens our sterile manufacturing capabilities and reinforces our commitment to sustainable, long-term growth. Throughout the transition, our priority remains the well-being, stability, and engagement of all employees.
A Strong Foundation
The Maisons-Alfort facility brings advanced sterile manufacturing capabilities, including aseptic filling for prefilled syringes and lyophilised vials, automated inspection systems, and sophisticated packaging operations.
As part of our network, the site will benefit from:
- Opportunities for long-term development
- Strengthened commercial reach and customer diversification
- Future investments supporting competitiveness
- Integration into a global CDMO with deep experience across Europe, the US, and Japan
The Promise of Joint Development
We are committed to supporting the continued development of the Maisons-Alfort site as a key part of our global strategy.
This momentum will enable the preparation of future growth through new products, increased volumes, and strengthened capabilities.
Our international growth relies on the full engagement of local teams across all countries.
A Human and Industrial Promise
Build a forward-looking project together, driven by collaboration and shared ambition.
Foster active, respectful, and transparent dialogue with employees, managers, and employee representatives.
Use a project-based approach to define the site’s roadmap and its strategic role within Adragos Pharma’s global network.
Implement industrial investments and introduce new equipment to relaunch the site’s momentum.
Highlight the site’s industrial heritage, technical expertise, and proven product quality.
Ensure success through collaboration across all teams: HR, operations, and upcoming new recruits.
Dr. Andreas Raabe
Founder & CEO
Quote from our CEO:
The acquisition of Maisons-Alfort is a major step for Adragos. We are bringing in a leading European site for pre-filled syringes and significantly strengthening our position in injectables.
Our ambition is clear: invest, scale, and transform the site into a top-tier fill-finish CDMO asset within our global network.
Your Expertise, Our Commitment, A Future We Shape Together.
Meet Our People
Our leadership team has a long-standing and impressive track record in the pharmaceutical industry and CDMOs, demonstrating expertise and experience.
